Dana-Farber researchers find that drug combination delays worsening of disease in women with recurrent ovarian cancer

Researchers from the Susan F. Smith Center for Women’s Cancers at Dana-Farber report that for some women with recurrent ovarian cancer, a new drug combination has been found to stall the progression of the disease. …read more

Source: Cancer